What's Happening?
Lisa G. Roth, MD, a nationally recognized pediatric oncologist and lymphoma survivor, has been appointed as the director of the Division of Pediatric Hematology-Oncology at Hassenfeld Children’s Hospital at NYU Langone. Dr. Roth, who previously studied
at NYU Langone Health, returns from Weill Cornell Medicine and NewYork-Presbyterian Hospital, where she led a research program focused on lymphomas affecting children, adolescents, and young adults. In her new role, Dr. Roth will oversee clinical care, research, and education programs, aiming to expand access to advanced therapies and clinical trials. Her work primarily focuses on lymphomas, including Hodgkin lymphoma, with the goal of developing more effective treatments. Dr. Roth succeeds Elizabeth A. Raetz, MD, who has transitioned to a new role as vice chair for clinical affairs in the Department of Pediatrics.
Why It's Important?
Dr. Roth's appointment is significant as it brings a highly experienced and respected figure back to NYU Langone, enhancing the hospital's capabilities in pediatric cancer care and research. Her expertise in lymphomas and her leadership in national clinical trials are expected to advance treatment options and improve outcomes for young patients. This move also underscores NYU Langone's commitment to maintaining its status as a leading institution in pediatric oncology, providing comprehensive care and support to children and their families. The transition of leadership from Dr. Raetz to Dr. Roth is poised to continue the hospital's tradition of excellence in clinical care and research.
